Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,628 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01281254 | AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) | terminated | Phase 3 | 223 | AmgenINDUSTRY | 18 | Dec 2, 2017 | clinicaltrials |
| NCT00903422 | Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) | completed | Phase 1 | 98 | GlaxoSmithKlineINDUSTRY | 11 | Nov 13, 2017 | clinicaltrials |
| NCT02419118 |
| "Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "(DARA) |
| completed |
| Phase 2 / Phase 3 |
| 4 |
| Vejle HospitalOTHER |
| 1 |
| Nov 7, 2017 |
| clinicaltrials |
| NCT01060761 | Involvement of Patients and Relatives in the Course of Cancer Disease(KRIPP) | completed | N/A | 42 | University of Southern DenmarkOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01853865 | Follow-up of Endometrial Cancer Patients(OPAL) | unknown | N/A | 211 | Odense University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03330301 | D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life(D-tect) | completed | — | 222,776 | Bispebjerg HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02886026 | Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors(LaserIII) | unknown | N/A | 248 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Nov 1, 2017 | clinicaltrials |
| NCT01213758 | Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT | completed | — | 14 | University of AarhusOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02232672 | Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer | withdrawn | N/A | 0 | Odense University HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT02329795 | Image-derived Prediction of Response to Chemo-radiation in Glioblastoma(IDEPREG) | terminated | — | 16 | Rigshospitalet, DenmarkOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT02066363 | Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer | terminated | N/A | 47 | Odense University HospitalOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT00531687 | Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer | terminated | Phase 2 | 8 | Rigshospitalet, DenmarkOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT03280407 | NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer(NEOLAR) | unknown | Phase 2 | 124 | Zealand University HospitalOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00943826 | A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma | completed | Phase 3 | 921 | Hoffmann-La RocheINDUSTRY | 24 | Sep 25, 2017 | clinicaltrials |
| NCT02403024 | Feasibility and Efficacy of Interval Walking in Patients With Colorectal Cancer | completed | N/A | 39 | Rigshospitalet, DenmarkOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01351415 | A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 485 | Hoffmann-La RocheINDUSTRY | 18 | Sep 18, 2017 | clinicaltrials |
| NCT01819649 | Selenium in the Prevention of Cancer(DK PRECISE) | completed | N/A | 491 | Odense University HospitalOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01918254 | A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein | completed | Phase 1 | 66 | Hoffmann-La RocheINDUSTRY | 4 | Sep 12, 2017 | clinicaltrials |
| NCT02320448 | Treating Peritoneal Carcinomatosis With PIPAC | completed | Phase 2 | 35 | Michael Bau MortensenOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT01416181 | A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis(ASCEND in SPMS) | terminated | Phase 3 | 889 | BiogenINDUSTRY | 17 | Sep 11, 2017 | clinicaltrials |
| NCT00241722 | Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 805 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 17 | Aug 30, 2017 | clinicaltrials |
| NCT01696045 | Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma | terminated | Phase 2 | 14 | Bristol-Myers SquibbINDUSTRY | 8 | Aug 29, 2017 | clinicaltrials |
| NCT02482090 | TIL Therapy for Metastatic Ovarian Cancer | completed | Phase 1 | 6 | Inge Marie SvaneOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT01901991 | Localization of Nonpalpable Breast Lesions | completed | N/A | 410 | Rigshospitalet, DenmarkOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT00090051 | FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients | completed | Phase 3 | 552 | Hoffmann-La RocheINDUSTRY | 17 | Aug 1, 2017 | clinicaltrials |
| NCT01143753 | A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors | completed | Phase 1 | 45 | Hoffmann-La RocheINDUSTRY | 3 | Jul 28, 2017 | clinicaltrials |
| NCT01733823 | DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole | completed | Phase 1 / Phase 2 | 31 | Danish Head and Neck Cancer GroupNETWORK | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02149108 | Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) | completed | Phase 3 | 768 | Boehringer IngelheimINDUSTRY | 25 | Jul 21, 2017 | clinicaltrials |
| NCT02561533 | Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma | completed | N/A | 53 | University of AarhusOTHER | 1 | Jul 14, 2017 | clinicaltrials |
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | terminated | Phase 3 | 2,867 | PfizerINDUSTRY | 36 | Jun 26, 2017 | clinicaltrials |
| NCT02738827 | Diode Laser Treatment of Bladder Tumors | completed | N/A | 21 | Gregers Gautier HermannOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01360554 | ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer(ARCHER 1009) | completed | Phase 3 | 878 | PfizerINDUSTRY | 23 | May 24, 2017 | clinicaltrials |
| NCT01684878 | Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) | completed | Phase 3 | 208 | Hoffmann-La RocheINDUSTRY | 10 | May 23, 2017 | clinicaltrials |
| NCT01288573 | A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone | completed | Phase 1 / Phase 2 | 46 | Genzyme, a Sanofi CompanyINDUSTRY | 12 | May 16, 2017 | clinicaltrials |
| NCT01524848 | Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib(PAGIST) | completed | Phase 2 | 72 | Scandinavian Sarcoma GroupOTHER | 5 | May 10, 2017 | clinicaltrials |
| NCT02356627 | The Cancer Home Life Intervention Study. A Randomised, Controlled Multicentre Trial and a Health Economic Evaluation | completed | N/A | 242 | University of Southern DenmarkOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT03147326 | Diagnostic Imaging of Myeloma Bone Lesions(RAMP) | completed | N/A | 14 | Herlev HospitalOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT02069470 | The Effect of CME on Early Cancer Diagnosis in General Practice | completed | N/A | 689 | University of AarhusOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02420067 | Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients | recruiting | — | 380 | Marie Luise Bisgaard, MDOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03134261 | Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients(DIMAB) | unknown | N/A | 300 | Herlev HospitalOTHER | 1 | May 5, 2017 | clinicaltrials |
| NCT00045032 | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer(HERA) | completed | Phase 3 | 5,099 | Hoffmann-La RocheINDUSTRY | 33 | Apr 27, 2017 | clinicaltrials |
| NCT02308384 | A Trial of the Implementation of iFOBT in General Practice | completed | N/A | 825 | University of AarhusOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT00413192 | E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 128 | Eisai Inc.INDUSTRY | 5 | Apr 26, 2017 | clinicaltrials |
| NCT02985424 | Polymyalgia Rheumatica and Giant Cell Arteritis | unknown | — | 80 | Svendborg HospitalOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT00816049 | ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy(ALL2008con) | completed | Phase 3 | 775 | Rigshospitalet, DenmarkOTHER | 5 | Apr 21, 2017 | clinicaltrials |
| NCT00819351 | ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase | completed | Phase 3 | 650 | Rigshospitalet, DenmarkOTHER | 5 | Apr 21, 2017 | clinicaltrials |
| NCT00925899 | Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer | completed | Phase 2 / Phase 3 | 72 | Bispebjerg HospitalOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02140593 | The Laparotomy Study | completed | Phase 4 | 128 | Herlev HospitalOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02043002 | Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI) | completed | N/A | 67 | University of AarhusOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT03113318 | Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer | unknown | N/A | 200 | Rigshospitalet, DenmarkOTHER | 1 | Apr 13, 2017 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials